The invention relates to new thienotriazolodiazepine derivatives of the formula (1) wherein R1 is CH3, R2 is CH3 or —(CH2)n—R4 or —(CH2)n—O—R4 or —(CH2)n—S—R4 wherein n is 1, 2, 3 or 4 and R4 is CH3, CH2CH3 or CH2CH2OCH3, and R3 is hydrogen or —OCH2O— or —OCH2CH2O— connected to the ortho/meta position or meta/para position of the phenyl ring; or wherein R1 and R2 are hydrogen and R3 is —OCH2O— Or —OCH2CH2O— connected to the ortho/meta position or meta/para position of the phenyl ring; and pharmaceutically acceptable acid addition salts thereof. These compounds and pharmaceutical compositions containing them are useful in the treatment and prevention of atherosclerotic artery diseases, such as myocardial infarction and stroke, and of Alzheimer's disease.
本发明涉及一种新的
噻唑三唑二氮杂环衍
生物,其
化学式为(1),其中R1为
CH3,R2为 或—(
CH2)n—R4或—( )n—O—R4或—( )n—S—R4,其中n为1、2、3或4,R4为 、 或 O ,R3为氢或连接到苯环的邻/间位或间/对位的—O O—或—O O—;或其中R1和R2为氢,R3为连接到苯环的邻/间位或间/对位的—O O—或—O O—;以及其药学上可接受的酸加盐。这些化合物和含有它们的制药组合物在治疗和预防动脉粥样硬化性疾病,如心肌梗塞和中风,以及阿尔茨海默病方面有用。